Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway - Wu, L; Mo, W; Feng, J; Li, J; Yu, Q; Li, S (Br J Pharmacol, 2020)